ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy (Q73594864)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2000

Language	Label	Description	Also known as
English	ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy	scientific article published on 01 March 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

Matthieu Carton

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Xavier Sastre-Garau

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Vincent-Salomon

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Freneaux

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Palangie

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Beuzeboc

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Mouret

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P de Crémoux

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

O Coué

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Zafrani

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Nicolas

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Clough

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Fourquet

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Pouillart

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

586-591

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Understanding adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic alterations in early-onset invasive breast carcinomas: correlation of c-erbB-2 amplification detected by fluorescence in situ hybridization with p53 accumulation and tumor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900339-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(99)00339-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10738122%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73594864&oldid=2243343520"